Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 13 results

Author Title [ Type

] Year

Filters: Author is Klein, M [Clear All Filters]

Conference Paper

Chew, E. Y., Clemons, T. E., Bressler, S., Klein, M., Ruby, A., Seddon, J., & Group, A. - R. Eye Diseas. (2005). Serum Nutrient Levels as Risk Factors for Neovascular AMD. In Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO). presented at the 01/05/2005, Fort Lauderdale, FL. Retrieved from http://www.arvo.org/Conferences_and_Courses/Past_Conferences/

Journal Article

Seddon, J., Gensler, G., Milton, R., Klein, M., & Rifai, N.. (2004). Association between C-Reactive Protein and Macular Degeneration. JAMA, 291, 704-710. presented at the 2004.

Lindblad, A., Lloyd, P., Clemons, T., Gensler, G., ,, Klein, M., et al.. (2009). Change in Area of Geographic Atrophy in the Age-Related Eye Disease Study: AREDS Report Number 26. Arch Ophthalmol, 127, 1168-1174. presented at the 09/2009. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19752426

Seddon, J., Gensler, G., Klein, M., & Milton, R.. (2006). C-Reactive Protein and Homocysteine are Associated With Dietary and Behavioral Risk Factors for Age-Related Macular Degeneration. Nutrition, 22, 441-443. presented at the 04/2006. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/%2016530626

Kopplin, L., R Jr., I., Wang, Y., Sivakumaran, T., Hagstrom, S., Peachey, N., et al.. (2010). Genome-Wide Association Identifies SKIV2L and MYRIP as Protective Factors for Age-Related Macular Degeneration. Genes Immun, 11, 609-621. presented at the 12/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20861866

Bures, R., Gaitan, A., Zhu, T., Graziosi, C., McGrath, K. M., Tartaglia, J., et al.. (2000). Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus Type 1. AIDS Res HumRetroviruses, 16, 2019-35. presented at the 2000.

Bures, R., Gaitan, A., Zhu, T., Graziosi, C., McGrath, K. M., Tartaglia, J., et al.. (2000). Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses, 16(18), 2019-35. presented at the 2000 Dec 10. doi:10.1089/088922200750054756

Sangiovanni, J., Arking, D., Iyengar, S., Elashoff, M., Clemons, T., Reed, G., et al.. (2009). Mitochondrial DNA Variants of Respiratory Complex I That Uniquely Characterize Haplogroup T2 Are Associated with Increased Risk of Age-Related Macular Degeneration. PLoS One, 4, e5508. presented at the 05/2009. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed?term=19434233

Cukras, C., Agron, E., Klein, M., ,, Chew, E., Gensler, G., et al.. (2010). Natural History of Drusenoid Pigment Epithelial Detachment in Age-Related Macular Degeneration: Age-Related Eye Disease Study Report No. 28. Ophthalmology, 117, 489-499. presented at the 03/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20079925

Klein, M., ,, Francis, P., Lindblad, A., Chew, E., Hamon, S., & Ott, J.. (2010). Progression of Geographic Atrophy and Genotype in Age-Related Macular Degeneration. Ophthalmology, 117, 1554-1559, 1559 e1551. presented at the 08/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20381870

Belshe, R. B., Stevens, C., Gorse, G. J., Buchbinder, S., Weinhold, K., Sheppard, H., et al.. (2001). Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers. J Infec Dis, 183, 1343-52. presented at the 2001.

Belshe, R. B., Stevens, C., Gorse, G. J., Buchbinder, S., Weinhold, K., Sheppard, H., et al.. (2001). Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers. J Infect Dis, 183(9), 1343-52. presented at the 2001 May 01. doi:10.1086/319863

Group, A. - R. Eye Diseas, Chew, E., Clemons, T. E., SanGiovanni, J. P., Danis, R., ,, et al.. (2014). Secondary Analyses of the Effects of Lutein/Zeaxanthin on Age-Related Macular Degeneration Progression: AREDS 2 Report Number 3. JAMA Ophthalmol, 132, 142-149. presented at the 02/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24310343